Background In July 2018 the active transcutaneous bone conduction hearing implant
received FDA approval in the US (for patients 12 years and older with conductive and/or …

Objectives This systematic review provides an overview of the available studies (published
by January 29, 2018) with descriptive data analysis about the influence of cochlear …

The objective of this study is to evaluate the safety and efficacy of a new transcutaneous
bone-conduction implant (BCI BB) in patients with conductive and mixed hearing loss or with …

Abstract Aim This European multicentric study aimed to prove safety and performance of the
Bonebridge BCI 602 in children and adults suffering from either conductive hearing loss …

Objective Implantable hearing devices represent a modern and innovative solution for
hearing restoration. Over the years, these high-tech devices have increasingly evolved but …

Objective: The Cochlear™ Osia® System (Osia) is an active transcutaneous bone
conduction implant system intended for patients with conductive and mixed hearing loss but …

Abstract Treatment with cochlear implants (CIs) in single-sided deaf individuals started less
than a decade ago. CIs can successfully reduce incapacitating tinnitus on the deaf ear and …

The aim of this study was to examine the functional hearing results regarding speech
perception and auditory sound localization in a high-resolution directional hearing setup …

Objective: To evaluate the audiological and subjective benefit from hearing rehabilitation
with an active bone conduction implant in subjects with single-sided sensorineural deafness …

Summary AIM OF THE STUDY: The aim of this multicentre, prospective, open,
nonrandomised clinical trial was to demonstrate the clinical efficiency and outcomes of …